Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can electrical muscle stimulation boost exercise benefits after menopause?

NCT ID NCT07826754

Symptom relief Sponsor: High Institute of Sports and Physical Education of Kef Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are testing whether adding whole-body electromyostimulation (WB-EMS) to a supervised exercise program improves body composition, heart health, fitness, and quality of life in overweight or obese postmenopausal women. Thirty women aged 48 to 60 will join a 16-week program with two sessions per week. Half will exercise with electrical stimulation delivered through electrodes, and half will do the same exercises without stimulation. The trial compares the two groups to see if the electrical pulses add extra benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
whole-body electromyostimulation (WB-EMS) training
What this could lead to
If it works, WB-EMS could offer postmenopausal women a time-efficient way to improve body composition, heart health, and fitness alongside standard exercise.
What could go wrong
This is a small, short trial of 30 women, so any benefits may be modest and may not apply to other groups. Electrical stimulation can cause muscle soreness or skin irritation, and the supervised exercise itself may be hard for some to tolerate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

48 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body mass index (BMI) ≥25 kg/m² * Age 48-60 years * Postmenopausal status, defined as amenorrhea for \>12 consecutive months * Stable eating habits Exclusion Criteria: * Any medical condition or contraindication that prevents participation in physical exercise * Cardiovascular diseases (hypertension or heart failure) * Metabolic or inflammatory disorders (uncontrolled diabetes mellitus or autoimmune diseases)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiometabolic health in overweight/obese postmenopausal women are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiometabolic health in overweight/obese postmenopausal women

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • High Institute of Sport and Physical Education of Kef, University of Jendouba Kef, Boulifa, Tunisia, 7100

    Tunis, Boulifa, 7100, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.